PL2318427T3 - Glukokortykoidy przyłączone do estrów kwasu azotowego poprzez aromatyczną grupę łączącą w pozycji 21 i ich zastosowanie w okulistyce - Google Patents

Glukokortykoidy przyłączone do estrów kwasu azotowego poprzez aromatyczną grupę łączącą w pozycji 21 i ich zastosowanie w okulistyce

Info

Publication number
PL2318427T3
PL2318427T3 PL09780232T PL09780232T PL2318427T3 PL 2318427 T3 PL2318427 T3 PL 2318427T3 PL 09780232 T PL09780232 T PL 09780232T PL 09780232 T PL09780232 T PL 09780232T PL 2318427 T3 PL2318427 T3 PL 2318427T3
Authority
PL
Poland
Prior art keywords
ophthalmology
glucocorticoids
attached
nitrate esters
esters via
Prior art date
Application number
PL09780232T
Other languages
English (en)
Inventor
Francesca Benedini
Annalisa Bonfanti
Valerio Chiroli
Rebecca Steele
Ennio Ongini
Stefano Biondi
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of PL2318427T3 publication Critical patent/PL2318427T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09780232T 2008-07-31 2009-07-07 Glukokortykoidy przyłączone do estrów kwasu azotowego poprzez aromatyczną grupę łączącą w pozycji 21 i ich zastosowanie w okulistyce PL2318427T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8529408P 2008-07-31 2008-07-31
US12289608P 2008-12-16 2008-12-16
PCT/EP2009/058572 WO2010012567A1 (en) 2008-07-31 2009-07-07 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
EP20090780232 EP2318427B1 (en) 2008-07-31 2009-07-07 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology

Publications (1)

Publication Number Publication Date
PL2318427T3 true PL2318427T3 (pl) 2014-05-30

Family

ID=41170981

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09780232T PL2318427T3 (pl) 2008-07-31 2009-07-07 Glukokortykoidy przyłączone do estrów kwasu azotowego poprzez aromatyczną grupę łączącą w pozycji 21 i ich zastosowanie w okulistyce

Country Status (21)

Country Link
US (2) US8518920B2 (pl)
EP (1) EP2318427B1 (pl)
JP (1) JP5520948B2 (pl)
KR (1) KR20110041496A (pl)
CN (1) CN102131821B (pl)
AR (1) AR075263A1 (pl)
AU (1) AU2009277381B2 (pl)
BR (1) BRPI0916702A2 (pl)
CA (1) CA2731513C (pl)
DK (1) DK2318427T3 (pl)
ES (1) ES2442720T3 (pl)
HK (1) HK1160142A1 (pl)
IL (1) IL210477A0 (pl)
MX (1) MX2011001119A (pl)
NZ (1) NZ590454A (pl)
PL (1) PL2318427T3 (pl)
PT (1) PT2318427E (pl)
RU (1) RU2501804C2 (pl)
SI (1) SI2318427T1 (pl)
WO (1) WO2010012567A1 (pl)
ZA (1) ZA201100636B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5791064B2 (ja) * 2009-07-17 2015-10-07 エア・ウォーター株式会社 医薬用組成物
EP2651403B1 (en) * 2010-12-17 2020-12-02 Glaxo Group Limited Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
WO2013133980A1 (en) * 2012-03-05 2013-09-12 Bausch & Lomb Incorporated Nitroxy derivatives of soft steroids
WO2015002427A1 (ko) * 2013-07-01 2015-01-08 (주) 엘지화학 폴리오르가노실록산 화합물, 제조방법 및 이를 포함하는 코폴리카보네이트 수지
CN110862318B (zh) * 2019-10-24 2022-05-13 甘肃省化工研究院有限责任公司 一种叔丁基取代羟基苯甲酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
ITMI20020148A1 (it) 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
BRPI0614967A2 (pt) * 2005-09-02 2013-01-01 Nicox Sa compostos, uso dos mesmos, formulação farmacêutica tópica, e, processo para a preparação de um composto
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.

Also Published As

Publication number Publication date
HK1160142A1 (en) 2012-08-10
CA2731513C (en) 2016-09-20
US9012435B2 (en) 2015-04-21
CN102131821A (zh) 2011-07-20
AR075263A1 (es) 2011-03-23
JP5520948B2 (ja) 2014-06-11
BRPI0916702A2 (pt) 2015-11-10
CN102131821B (zh) 2014-08-27
IL210477A0 (en) 2011-03-31
WO2010012567A1 (en) 2010-02-04
EP2318427B1 (en) 2013-10-23
EP2318427A1 (en) 2011-05-11
AU2009277381A1 (en) 2010-02-04
KR20110041496A (ko) 2011-04-21
US20110144073A1 (en) 2011-06-16
DK2318427T3 (da) 2014-01-20
ZA201100636B (en) 2011-10-26
RU2011106173A (ru) 2012-09-10
RU2501804C2 (ru) 2013-12-20
PT2318427E (pt) 2014-01-22
ES2442720T3 (es) 2014-02-13
SI2318427T1 (sl) 2014-02-28
CA2731513A1 (en) 2010-02-04
MX2011001119A (es) 2011-03-02
JP2011529461A (ja) 2011-12-08
US20130303499A1 (en) 2013-11-14
US8518920B2 (en) 2013-08-27
NZ590454A (en) 2012-09-28
AU2009277381B2 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
PL2327694T3 (pl) Podstawione kwasy 4-aminopikolinowe i ich zastosowanie jako herbicydów
IL208759B (en) History of 2-cyanooleanolic acid modulated at position 17 and their use as anti-inflammatory antioxidants
HK1145652A1 (en) Materials and methods for delivering compositions to selected tissues
PL2364975T3 (pl) Nowa pochodna amidu i jej zastosowanie jako lek
HK1160142A1 (en) Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology 21
GB0921803D0 (en) Drug composition and its use in therapy
GB0820877D0 (en) Improvements in or relating to medicament dispensers
EP2279999A4 (en) RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
GB0919889D0 (en) Drug composition and its use in therapy
GB2464318B (en) Improvements in and relating to furniture
IL216205A0 (en) Use of lipid conjugates in the treatment of diseases associated with vasculature
GB0921805D0 (en) Drug composition and its use in therapy
GB0919893D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
IL208824A0 (en) Iminopyridine derivative and use thereof
GB0623245D0 (en) Improvements in and relating to calorimetry
GB0715985D0 (en) Improvements in and relating to tree stands
GB0823385D0 (en) Improvements in or relating to storage and display
GB0823381D0 (en) Improvements in or relating to storage and display
GB0823384D0 (en) Improvements in or relating to storage and display
GB0823383D0 (en) Improvements in or relating to storage and display
GB0724893D0 (en) Improvements in or relating to storage and display
GB0724891D0 (en) Improvements in or relating to storage and display
GB0724889D0 (en) Improvements in or relating to storage and display
GB0922273D0 (en) Improvements in or relating to storage and display